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Expression of immunoreceptor tyrosine-based activation motif (ITAM)-containing signaling 
proteins is normally restricted to hematopoietic tissues. The basal activity of ITAM-
containing proteins is mediated through negative regulation by coreceptors restricted to 
hematopoietic tissues. We have identified an ITAM signaling domain encoded within the 
 
env
 
 
gene of murine mammary tumor virus (MMTV). Three-dimensional structures derived in 
vitro from murine cells stably transfected with MMTV 
 
env
 
 display a depolarized morphology 
in comparison with control mammary epithelial cells. This effect is abolished by Y
 
 
 
F 
substitution within the Env ITAM, as well as inhibitors of Syk and Src protein tyrosine 
kinases. Env-expressing cells bear hallmarks of cell transformation such as sensitivity to 
apoptosis induced by tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) 
or TNF
 
 
 
, as well as down-regulation of E-cadherin and Keratin-18. Human normal 
mammary epithelial cells expressing MMTV Env also develop transformed phenotype, as 
typified by growth in soft agar and Matrigel invasion. These disruptions are abrogated by 
Y
 
 
 
F substitutions. We conclude that ITAM-dependent signals are generated through MMTV 
Env and trigger early hallmarks of transformation of mouse and human mammary epithelial 
cells. Therefore, these data suggest a heretofore unappreciated potential mechanism for the 
initiation of breast cancer and identify MMTV Env and ITAM-containing proteins in human 
breast tumors as probable oncoproteins.
 
Immunoreceptor tyrosine-based activation mo-
tifs (ITAMs) are signaling motifs associated with
activation, survival, and differentiation. ITAM-
containing proteins are expressed in many he-
matopoietic cells, including B and T lympho-
cytes, mast cells, platelets, and natural killer cells.
The amino acid sequence of ITAMs in these
tissues is highly conserved. The canonical motif
is denoted as: Yxx(L/I)x
 
6-8
 
Yxx(L/I). The tyro-
sines embedded in this motif are necessary and
sufficient for ITAM signaling function. Once
phosphorylated by intracellular protein tyrosine
kinases of the Src family, the ITAM-associated
tyrosines function as docking sites for SH2-
containing signaling proteins involved in link-
ing receptor-initiated signals to downstream
cellular responses such as proliferation, sur-
vival, and differentiation (1).
Our laboratory has recently found that
ITAM-containing proteins are able to generate
signals independently of the ligand-induced ag-
gregation that is typical of ITAM-containing re-
ceptor complexes (2–4). For ligand-independent
functions, positioning at the plasma membrane
appears necessary and sufficient for signal gener-
ation. Normally, in hematopoietic cells, these
ligand-independent signals can be constitutive,
but maintained at basal levels by a complex
balance between Src and Syk family tyrosine ki-
nases and protein tyrosine phosphatases, such as
SHP-1 and SHP-2 (5). These phosphatases are
localized to the cytoplasm until they are spatially
positioned to regions of the plasma membrane
occupied by the ITAM-containing proteins by
recruitment to hematopoietic-restricted trans-
membrane proteins with cytoplasmic ITIM (in-
hibitory) motifs (1). The current model for
this signaling would predict that expression of
ITAM-containing plasma membrane proteins
outside of hematopoietic tissues where this regu-
lation may be absent could lead to deregulated
and possibly hyperactive signaling.
Mouse mammary tumor virus (MMTV) is
a 
 
 
 
-retrovirus that is acquired through milk
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and causes adenocarcinomas of adult mammary epithelial tis-
sue. MMTV uses Toll-like receptors 2 and 4 and the trans-
ferrin receptor for viral binding and entry (6). The initial tar-
gets of infection by MMTV are B and dendritic cells,
generally of the Peyer’s patches, although T cells can also be
infected (7) and transformed (8, 9). In general, MMTV-
infected B cells and dendritic cells do not undergo malignant
transformation (7, 10). Instead, B cells generate virus parti-
cles that, upon transfer to mammary epithelial cells, result in
the transformation of these secondary targets (11). In the ab-
sence of B cells, the mammary epithelial cells of mice ex-
posed to MMTV are not infected and do not form tumors
(12). T cells likely play an important role in the pathogenesis
of mammary tumors by providing proliferative signals to in-
fected antigen-presenting cells that present superantigen on
their surface (13, 14).
The transforming properties of MMTV have been gener-
ally considered to result from positional effects due to proviral
integration next to cellular proto-oncogenes. Specifically, cell
transformation by MMTV has been attributed to genetic in-
sertion near Wnt/FGF family genes (15). Nevertheless, ge-
netic evidence argues that these events cannot entirely
account for the transformation potential of MMTV. In par-
ticular, the 
 
gag
 
 and/or 
 
env
 
 gene products of the virus have
been linked to transformation in mammary tumor–suscepti-
ble mice (16). Furthermore, the incidence and latency of
mammary tumor induction in Wnt transgenic mice does not
differ substantially from those in MMTV-infected mice (15).
The expression of ITAM-containing proteins has largely
been found to be restricted to hematopoietic tissues. How-
ever, several oncogenic viruses with tropism for nonhemato-
poietic cells have been identified and subsequently shown to
encode plasma membrane-associated proteins containing ca-
nonical ITAMs. These proteins include Epstein Barr virus
LMP2A (17), Kaposi’s sarcoma virus K1 (18), and bovine
leukemia virus gp30 (19), among others. We have identified
a canonical ITAM encoded within the 
 
env
 
 gene of MMTV.
We show here that expression of the ITAM-containing
protein MMTV Env is sufficient to cause morphological
changes consistent with transformation in normal mouse and
human mammary epithelial cells in vitro. Env expression led
to phenotypic changes characteristic of breast cancer in mice
and humans in vivo. Specifically, in vitro expression of
MMTV Env led to loss of growth arrest, decreased apopto-
sis, and down-regulated expression of E-cadherin and Kera-
tin-18 in three-dimensional Matrigel cultures. These al-
terations resulted in profound disruption of the normal
polarized acinar structures typical of nontransformed mam-
mary epithelial cells in three-dimensional cultures, as well as
increased soft agar colony formation and Matrigel invasion.
These studies implicate ITAM-containing proteins as potent
oncoproteins. Furthermore, they suggest previously unap-
preciated roles for viral membrane ITAMs in the selective
transformation of nonhematopoietic tissues. Importantly,
they argue for a novel mechanism operative in the initiation
of mammary gland tumors.
 
RESULTS
Expression of ITAM-containing MMTV Env leads to 
depolarization of mammary epithelial acinar structures
 
The MMTV 
 
env
 
 gene encodes a type-1 membrane glyco-
protein that, after proteolytic cleavage, exists as two mature
proteins, the surface unit (SU or gp52) and the transmem-
brane unit (TM or gp36). The sequence, 418-PAYDYAAI-
IVKRPPYVLLPVDIGD-441, is located in the surface unit
of MMTV Env (Fig. 1 A). Previous genetic studies have not
targeted this sequence nor proposed its relevance in etiology
of breast epithelial cell transformation in the mouse.
To test whether the MMTV Env and its ITAM could
participate in MMTV-mediated transformation, we used
three-dimensional cultures of NMuMG murine mammary
epithelial cells. Three-dimensional recombinant basement
Figure 1. The contribution of ITAM domain in MMTV Env to cell 
transformation. (A) Schematic comparison of the ITAM in MMTV Env and 
consensus ITAM sequence. The conserved residues are shaded. (B) Devel-
opment of mammary epithelial cell acinar structures on Matrigel. The de-
polarization resulting from MMTV Env expression may lead to loss of the 
spherical structures. (C) Representative images of three-dimensional cultures 
of wild-type (WT), mutated (Y422 F, Y432 F) envelope-transfected, envelope-
transfected, and MMTV  NMuMG clone 1 NMuMG cells are shown at day 
6 of culture. For WT and F6, the images are also shown at a magnification 
of 4 of the originals. Note the polarized structures with hollow lumen in 
both cell types. Bars, 50  m. (D) Quantification of structure size in a repre-
sentative experiment (20–60 structures counted for each cell line). The 
black bars represent the median for each culture. Surface expression of 
MMTV SU (gp52) is shown for mutated (Y422 F, Y432 F) Env  and Env  
NMuMG cells. Normal goat IgG was used as the control antibody. 
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membrane cultures provide a unique opportunity to model
the acinar architecture of mammary epithelium in vivo (for
review see references 20, 21). Unlike monolayer (two-
dimensional) cultures, mammary epithelial cells grown in
three-dimensional cultures recapitulate numerous features of
breast epithelium in vivo. These include the formation of
growth-arrested polarized acini with hollow lumen and de-
position of basement membrane components, such as col-
lagen IV and laminin V (22, 23). Three-dimensional cultures
provide the appropriate structural and functional context for
studying the events involved in morphogenesis of glandular
epithelium. Furthermore, three-dimensional cultures pro-
vide the opportunity to study the molecular mechanisms
necessary to form and maintain a normal glandular architec-
ture and to determine how oncogenes disturb this highly or-
ganized structure. Three-dimensional cultures have recently
been used in a variety of biological assays, including deter-
mining the contribution of ErbB2/HER2 (22), 
 
 
 
-integrins
(24), and Syk tyrosine kinase (25) to mammary epithelial
growth regulation.
We chose the normal murine mammary epithelial cell
line NMuMG as our initial model as this cell line has
been used in the past to study MMTV-mediated infec-
tion and transformation (7, 26). A stably transfected pool,
NMuMG.Q4, was established, expressing both the SU and
TM subunits of the MMTV Env. Cells from this line, to-
gether with mock-transfected NMuMG cells, were seeded
in three-dimensional cultures, on a Matrigel cushion. When
grown in two-dimensional cultures, these cells did not ap-
pear morphologically different from the parental NMuMG
cell line and did not show any reproducible growth rate ad-
vantage (unpublished data). Nonetheless, depolarization of
acinar structure was easily visible in three-dimensional Matri-
gel cultures (Fig. 1 B). As with other three-dimensional cul-
tures (23, 27), within the first 6 d, WT mock-transfected
NMuMG cells were observed to form a polarized disc struc-
ture (Fig. 1 C). In this timeframe, morphological differences
between mock-transfected cells and Env-expressing cells
were readily apparent. Expression of MMTV Env alone was
sufficient to generate depolarized acini in frequencies rang-
ing between 30–90% of all structures (nine independent ex-
periments). The differences in depolarization are likely to re-
flect the variable Env expression levels in the Env
 
 
 
 Q4 line.
For receptor complexes that contain ITAM-containing
proteins, signaling is initiated by phosphorylation of the ty-
rosine residues associated with the ITAM. These phosphoty-
rosine residues interact with proteins from two families of
tyrosine kinases: the Syk/Zap-70 family and the larger Src
family (28). Therefore, we determined the contribution of
the tyrosine residues in the ITAM domain of Env SU pro-
tein. An additional stable transfected pool was generated,
NMuMG.F6, that expressed the MMTV Env with two
Y
 
 
 
F substitutions (Env
 
2xY
 
 
 
F
 
) in the ITAM region of SU
(amino acids 422 and 432 in MMTV [C3H] sequence). The
Env
 
2xY
 
 
 
F
 
 line was almost indistinguishable from wild-type or
mock-transfected cells (Fig. 1 C). Occasionally in three-
dimensional cultures of wild-type or Env
 
2xY
 
 
 
F
 
 cells, an en-
larged structure could be observed, but the frequency of
those was always low (six independent experiments; Fig.
1 D) and similar to those observed in mock-transfected
NMuMG cells. Differences in surface expression levels of
MMTV SU did not account for the observed differences in
transformation as expression in the Env-expressing and Env
ITAM mutant-expressing lines were equivalent (Fig. 1 B,
bottom). Also shown for comparison is the Env expression
level on an MMTV-transfected clone (C1), which is higher
than on the Env transfectants, verifying that the disruption in
the three-dimensional morphology observed is not the result
of an artifact of Env overexpression. These results illustrate a
striking and unexpected effect of MMTV Env expression on
mammary epithelial acinar structures in this in vitro model.
Importantly, tyrosine residues within Env were critical for
the depolarized morphology of mammary epithelial cells.
Figure 2. The involvement of Src and Syk kinases in MMTV Env-
induced cell transformation. (A) MMTV SU coprecipitates with Syk in a 
tyrosine-dependent manner. Env2xY F and Env  two-dimensional cultures 
were treated with sodium pervanadate and equal protein loads were used 
for MMTV SU or Syk immunoprecipitation. A Western blot for MMTV SU is 
shown. Syk coprecipitates only with Env, but not the 2xY F mutant (top). 
(B) Wild-type and Env  cultures were treated three dimensionally before 
imaging (at day 6) with either normal assay media, the Src kinase inhibitor 
PP2 (500 ng/ml), or the Syk kinase inhibitor Piceatannol (500 ng/ml). Bars, 
50  m. (C) Quantification of structure size in a representative experiment 
(20–60 structures counted for each cell line). The black bars represent the 
median for each culture. 
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These alterations are remarkably similar to those induced by
known breast oncogenes such as ErbB2/HER2 (22).
 
Src and Syk tyrosine kinases contribute to MMTV Env-induced 
acinar depolarization
 
In lymphocytes, ITAM signaling is dependent on activity of
two tyrosine kinase families, the Src family and the smaller
Syk/Zap-70 family (1). Constitutive signals stemming from
ITAM-containing proteins are of transient nature (5) and
their unmasking requires many times the usage of tyrosine
phosphatase inhibition (2). Under such conditions, direct in-
teraction between the MMTV SU and Syk kinase can be de-
tected, with up to 34% SU protein coprecipitates with Syk
(three independent experiments; Fig. 2 A). In agreement with
this observation, pharmacologic inhibitors of the Src (PP2)
and Syk/ZAP70 (piceatannol) protein tyrosine kinases are suf-
ficient to block morphological changes associated with Env
transformation (Fig. 2 B). Inhibition of either Syk/ZAP70 or
Src kinases resulted in the maintenance of the polarized struc-
tures. These results were quantified for one representative ex-
periment and are depicted in Fig. 2 C. The inhibitors are each
clearly effective in blocking the Env-dependent morphologi-
cal changes associated with transformation, although there is
some variability in the size of the structures.
 
MMTV Env-expressing cells exhibit transformed mammary 
epithelial phenotype
 
We also evaluated NMuMG cells stably expressing infectious
MMTV virus (clone 1; reference 26). MMTV
 
 
 
 clone 1 cells
show morphological features in three-dimensional cultures,
which resemble mesenchymal cells (Fig. 3 A). A higher level
of surface MMTV SU expression, in comparison with the
Env-expressing NMuMG line (Fig. 1 C) or positional effects
due to virus integration and long-term culture, may account
for the greater degree of depolarization observed for this line
(Fig. 3 A). These observations prompted us to look for more
specific markers of transformation in the three-dimensional
cultures of Env
 
 
 
 and MMTV
 
 
 
 cells. First, we examined spe-
cific markers of epithelial–mesenchymal transition. Both the
Env
 
 
 
 line and the MMTV
 
 
 
 clones have down-regulated
Keratin-18, suggesting an epithelial–mesenchymal transition
as a result of MMTV Env expression (Fig. 3 B and not
depicted). Similarly, E-cadherin expression was also ob-
served to be down-regulated in the Env-expressing line and
MMTV
 
 
 
 clone 1 (Fig. 3 B). Expression of E-cadherin and
Keratin-18 in NMuMG.F6 (double Y
 
 
 
F envelope mutant)
closely resembled wild-type and mock-transfected cells (un-
published data). Interestingly, down-regulation of E-cad-
herin surface expression can be detected already in Env-
expressing cells maintained in two-dimensional cultures
(Fig. 3 B, right).
Another hallmark of transformation and depolarization in
three-dimensional mammary epithelial cultures is sensitivity
to apoptosis induced by TNF-related apoptosis-inducing
ligand (TRAIL) and TNF
 
 
 
 (27). Accordingly, we tested the
sensitivity of the Env-expressing and nonexpressing cultures
for their sensitivity to these agents. Shown in Fig. 3 C, Env-
expressing but not WT or mock-transfected cells were ob-
served to be sensitive to the proapoptotic effects of these
agents as determined by their marked attenuated growth and
loss of the spreading, nonpolarized structures exhibited by
the Env-expressing cells grown in the absence of TNF
 
 
 
 or
TRAIL. These effects on Env-expressing cells were similar
to effects reported previously for mammary epithelial cells in
three-dimensional cultures transformed by known mammary
oncoproteins (24). Together, the depolarized structures
observed in the Env-expressing line and the MMTV
 
 
 
NMuMG clones exhibit known markers and hallmarks of
mammary cell transformation.
Figure 3. Expression of MMTV Env in murine mammary epithelial 
cells is sufficient for cell transformation. (A) Representative images of 
three-dimensional cultures, on Matrigel cushions, of wild-type and Env  
NMuMG cells are shown at day 6 of culture. Bars, 50  m. (B) Keratin-18 
staining of mock-transfected, Env , and MMTV clone 1 NMuMG cultures 
at day 6. Keratin-18 is in green and nuclear staining (DAPI) is in blue. 
(right) E-cadherin surface expression, as quantified by flow cytometry, is 
reduced in Env  and MMTV clone 1 NMuMG two-dimensional cultures. 
(C) Wild-type and Env  cultures were treated 17 h before imaging (at day 6) 
with either normal assay media, 1  g/ml TRAIL, or 100 nM TNF . The in-
duction of apoptosis was confirmed by TUNEL assays (not depicted). 
JEM VOL. 201, February 7, 2005
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Expression of MMTV Env leads to human mammary 
epithelial cell transformation
 
We determined the ability of MMTV Env to transform hu-
man mammary epithelial cells, to ascertain whether Env ex-
pression leads to phenotypes normally associated with breast
malignancy. We generated stable transfectants of the primary
human mammary epithelial line, MCF-10F, expressing either
WT Env
 
 
 
 (MCF-10F.Q400) or the Env
 
2xY
 
 
 
F
 
 envelope mu-
tant (MCF-10F.Y1). As in vitro parameters of cell transfor-
mation, we used two assays: colony formation in agar-meth-
ocel and three-dimensional growth in collagen matrix (Fig. 4
A). Although both cell lines produced colonies, colony for-
mation in the Env-expressing cells was significantly and re-
producibly more efficient (55–90% compared with only 25–
40% in Env ITAM mutant-expressing cells). Importantly, the
Q400 colonies were approximately twofold larger than those
of the ITAM mutant-expressing line. These differences were
more evident at earlier time points, where identifiable Env-
expressing colonies were detected as early as 5 d in culture.
A second approach to detection of the transforming
properties of the Env protein in human cells was to use a
collagen matrix assay, where mammary epithelial cells form
ductal structures resembling their organization in the mam-
mary gland. In Env-expressing cells, a notable loss of ductal
structure was observed in comparison with wild-type MCF-
10F cells and the ITAM mutant Env
 
 
 
 (Fig. 4 B). With Env
 
 
 
cells, only spherical structures could be seen.
Lastly, Matrigel invasion assays were conducted to evalu-
ate the invasive properties Env-expressing human cells. As
shown in Fig. 4 C, ITAM mutant Env
 
 
 
 cells were only
mildly invasive (
 
 
 
100 cells/25,000 cells seeded), whereas
Env
 
 
 
 cells were highly invasive with more than twice as
many cells scored in this assay. These studies extend our ob-
servations with mouse cells in demonstrating the transform-
ing properties of Env-expression in human mammary epi-
thelial cells.
 
DISCUSSION
 
The immune system relies heavily on the function of
ITAM-containing proteins. B cells, T cells, mast cells, mac-
rophages, and NK cells all depend on such molecules for
their activation and selection processes. The discovery of
ITAM-containing viral proteins outside the immune system
has led us to investigate what role they could play in a non-
hematopoietic context. Previously, viral ITAM-containing
proteins were examined almost exclusively within the con-
text of hematopoietic cells and little information existed re-
garding the functions of ITAM-containing proteins in a
nonhematopoietic context. Such studies are important for
two main reasons. First, there are clear indications that viral
ITAM-containing proteins may play role in a variety of can-
cers (29, 30). Second, recent studies have shown that cellular
ITAM-containing proteins can be expressed outside the im-
mune system (31–33). The function of these proteins is
largely unknown.
The data presented demonstrate the ability of the MMTV
Env ITAM-containing protein to initiate profound growth
and morphological changes that are consistent with malignant
transformation of mammary epithelial cells. Furthermore, we
show directly that the tyrosine residues in the MMTV SU
ITAM and the activation of Syk and Src kinases all play a
critical role in the transformation process. We propose that a
protein containing an ITAM domain generates a transform-
ing signal in both murine and human normal mammary epi-
Figure 4. MMTV Env also transforms human mammary epithelial 
cells. (A) Colony formation assay for wild-type, mutated (Y422 F, Y432 F) 
Env  and Env  MCF-10F cells. Colonies were defined as cell clusters  60  m 
in size. (right) The percentage of colonies formed in five agar-methocel cul-
tures in a representative experiment out of three independent experiments. 
(B) Representative images from collagen-matrix cultures of wild-type, 
mutated Env , and Env  MCF-10F cell lines (a representative experiment 
out of three independent experiments). Ductal structures are visible in 
wild-type cultures. Complete loss of ductal structure could be seen in 
Env  cultures, whereas mutated Env  culture exhibit a mixed phenotype. 
(C) Representative images from invasion assays of wild-type, mutated 
Env , and Env  MCF-10F cells. The three panels on the left are showing 
the stained mesh after the completion of the invasion assays. Invading 
cells were visualized by blue stain. The right panel shows total invading 
cell counts from a representative experiment (in duplicate) out of three in-
dependent experiments. 
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thelial cells. The signal generated relies on both Src and Syk
tyrosine kinases to exert its transforming capabilities, in a
mechanism similar to lymphocyte activation by the B and T
cell receptors (34). ITAM-based signaling is well character-
ized in hematopoietic cells. ITAM-based signaling in he-
matopoietic cells is tightly regulated by phosphatases, such as
SHP-1/2, as part of a negative regulatory loop that exists to
terminate the signal (5). It is possible that an analogous termi-
nation mechanism does not exist in mammary epithelial cells
and that this enables the generation of an unregulated consti-
tutive transforming signal. These studies suggest that MMTV
Env may contribute to MMTV-induced transformation. In
light of the previous model for MMTV-induced transforma-
tion, as reliant solely on positional integration, our findings
are remarkable and unexpected.
The investigation of viral ITAM-containing proteins
could lead to new insights regarding the way cancer is initi-
ated. Both KSHV K1 and EBV LMP2A were shown to be
capable of cell transformation (29, 30). K1 is capable of
transforming fibroblasts and ultimately leads to the develop-
ment of sarcomas (30). Furthermore, it also induces expres-
sion of angiogenic and invasion factors critical to cancer,
such as vascular endothelial growth factor (35). LMP2A was
shown to transform keratinocytes in vitro and tumorigenesis
in vivo (29). A few novel cellular ITAM-containing proteins
were also identified, such as the SIRP family (32) and the
neutrophil-restricted CEACAM3 (36). The function of
these proteins is largely unknown. Examination of the be-
havior of other viral ITAM-containing proteins could also
give some insights for a possible association of these se-
quences in the initiation or progression of mammary epithe-
lial transformation.
The work presented here suggests a new model for
mammary epithelial transformation. It is known that ITAM-
containing proteins, such as LMP2A, act in two modes of
operation: (a) disturbing existing tyrosine-based signaling
networks stemming from ITAM-containing complexes such
as the B or T cell receptors and (b) generating an indepen-
dent constitutive signal, which influences the physiology of
the host cell (37, 38). Similarly, MMTV Env could integrate
other known events in breast cancer tumorigenesis. Both
EGFR and 
 
 
 
4-integrin signaling are based on tyrosine phos-
phorylation. The ITAM domain on the SU portion of the
envelope protein could act in similar ways to LMP2A and
other viral proteins in drawing Src and Syk tyrosine kinases
off EGFR or 
 
 
 
4-integrin. According to current models,
such an alteration in EGF-based signaling could result in an
imbalance of both growth and apoptosis (39), leading to the
transformed phenotype we have observed (Figs. 1 and 3).
Furthermore, manipulation of 
 
 
 
4-integrin signaling could
induce anchor-independent growth, which is typical of ad-
vanced tumorigenesis (27), which we observed in the enve-
lope-expressing human mammary epithelial cells (Fig. 4).
Syk tyrosine kinase might play an important role as an inte-
grator of these signals. Syk activity was suggested to be criti-
cal for initiation of breast tumorigenesis, and its loss of ex-
pression was a marker for more advanced tumors (25).
In this paper, we establish functional relevance of the
ITAM in the context of MMTV Env-induced morphological
transformation. Like other retroviruses, MMTV encodes an
Env polyprotein that is cleaved to generate the gp52 surface
(SU) and gp36 subunits. The association of the SU and TM
was established more than two decades ago (40–42). In the
conventional model for retroviral envelope proteins, the en-
Figure 5. MMTV envelope sequence, domains, and topological 
models. (A) Schematic representation of MMTV Env protein and its do-
mains. Potential transmembrane domains are numbered and depicted in 
diagonally striped boxes. The ITAM region is marked in a shaded box. 
(B) Models for the surface expression of mature MMTV Env on the host 
cell surface. The domains are marked as in A. The hydrophobicity scores for 
the transmembrane domains were as follows: 1, 1,489; 2, 699; 3, 2,658; 
and 4, 3,134. 
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tire SU is extracellular (Fig. 5 B). Using algorithms de-
signed to predict transmembrane regions and orientation
(TMpred, http://www.ch.embnet.org/software/TMPRED_
form.html), we detected four putative transmembrane do-
mains in the MMTV Env protein (Fig. 5, diagonally striped
boxes), including one in its unusually long signal peptide
(transmembrane domain 1). These observations were con-
firmed by an additional program PHDhtm, which predicts
transmembrane helices (http://www.embl-heidelberg.de/
predictprotein/submit_adv.html). Importantly, Platt and Fire-
stone have evidence that transmembrane domain 3, which
normally mediates fusion during viral infection, can function
as a bona fide transmembrane domain under some circum-
stances (43). Alternative usage of all transmembrane domains
(Fig. 5 B, alternative model 1) or transmembrane domains 3
and 4 (Fig. 5 B, alternative model 2) will result in Env with a
cytoplasmic tail including the ITAM region of SU (Fig. 5 A,
shaded box). The most likely alternative model is alternative
model 2 because domains 3 and 4 are the most hydrophobic
domains and are similar in their capability to span the plasma
membrane.
Using three standard assays, we showed that Env-
expressing human cells were transformed and invasive (Fig.
4). Such phenotype is remarkable because it is typical of mam-
mary epithelial cells with high potential for tumorigenesis
and metastasis in humans. Several papers have documented
the presence of MMTV homology sequences in ex vivo iso-
lates of human breast epithelium tumors (44–47). These se-
quences were originally identified by their homology to the
Env protein of MMTV. Although this virus has long been
known to induce malignant transformation of mouse mam-
mary epithelial cells, a human equivalent of MMTV has only
been recently suggested (47), although it is still disputed
by many investigators. According to published evidence,
ITAM-mediated transformation could operate in a signifi-
cant proportion of human breast tumors (48). We have
generated predicted protein sequences in accordance with
MMTV Env homologous sequences published by Pogo et
al. (46). Out of 14 amino acid sequences analyzed, 5/11
(45%) breast cancer samples and 1/3 (33%) human mammary
cell lines showed considerable homology to MMTV SU, in-
cluding the putative ITAM motif. Moreover, three other
predicted protein sequences for the MMTV Env human ho-
mologue also include an intact ITAM domain (GenBank/
EMBL/DDBJ accession nos. AAF64164, AAK60129, and
AAP73835). In addition, although the surrounding region
has some homology to human endogenous retrovirus K, ret-
roviruses of this family do not possess an ITAM sequence
(unpublished data).
In summary, signaling through ITAM sequences may
play an important part in mammary epithelial transforma-
tion. Whether those effects represent early initiation pro-
cesses or are sufficient for tumorigenesis in vivo remains an
issue for further in depth study. Additional studies are also
necessary to explore the precise molecular mechanism en-
abling such rapid and invasive tumors to develop, as the re-
sult of the expression of this protein. In the long term, un-
derstanding this mechanism will enable a new approach to
possible treatments for breast cancer.
 
MATERIALS AND METHODS
 
Cell lines.
 
The NMuMG and MCF-10F cell lines were obtained from
the American Type Culture Collection.
 
 
 
MMTV-transfected clones of the
NMuMG cell line, clone 1, were generated as reported previously (26). All
NMuMG cell lines were maintained in DMEM containing 10% heat-inac-
tivated FBS, 2 mM 
 
L
 
-glutamine, 100 U/ml penicillin-streptomycin, and 10
 
 
 
g/ml insulin at 37
 
 
 
C and 5% CO
 
2
 
.
Cell transfections were accomplished using the GenePorter system
(Gene Therapy Systems) according to the manufacturer’s instructions. The
Q61 plasmid was used for complete envelope expression (26). Mutations in
the MMTV SU tyrosine residues (Y
 
 
 
F) were introduced using the Quick-
change XL kit from Stratagene. Stable pools were generated and maintained
by sorting for SU
 
hi
 
 expressing cells every 5–10 passages.
 
Flow cytometry.
 
Cells grown in two-dimensional cultures (10
 
6
 
) were an-
alyzed for flow cytometry on FACSCalibur (BD Biosciences). Goat poly-
clonal anti-SU (26) or rat anti–human E-cadherin (Sigma-Aldrich) were
used as primary antibody and donkey anti–goat IgG-FITC conjugated or
goat anti–rat IgG-Cy5 conjugated were used as secondary antibody (Jackson
ImmunoResearch Laboratories). Normal goat IgGs or rat IgGs were used as
the negative control.
 
Three-dimensional cultures.
 
NMuMG cells (5 
 
 
 
 10
 
3
 
 cells per chamber)
were cultured on Matrigel (BD Biosciences) cushions following the precise
protocol published previously (23) in the absence of exogenous EGF. The
structures were analyzed, at a magnification of 20, on a Zeiss Axiovert
200M equipped with PCO SensiCam video camera and Slidebook software
(Intelligent Imaging Innovations). Cell staining was performed as described
previously (23) with rat anti–human Keratin-18 (Lab Vision), rat anti–
human E-cadherin and goat anti–rat IgG-FITC conjugated antibodies
(Jackson ImmunoResearch Laboratories), or goat anti–rat IgG-Alexa-555
conjugated antibodies (Molecular Probes). Quantification of structure size
was done using a 10 
 
 
 
 50-
 
 
 
m grid reticule (Fisher Scientific) and 20–100
structures were counted from each chamber. The inhibitors PP2 and Piceat-
annol (EMD) were added on day 3 of culture and pictures were taken on
day 6. In apoptosis assays, TNF
 
 
 
 (R&D Systems) or TRAIL (BIOMOL
Research Laboratories, Inc.) were added on day 5 culture and pictures were
taken on day 6. TUNEL assay (Roche) was performed according to the
manufacturer’s instructions (except that all steps were done in room
temperature).
 
Cell lysis, immunoprecipitation, and Western blotting.
 
Cells grown
in two-dimensional cultures to confluency were stimulated with 50 mM so-
dium pervanadate as described previously (2) and harvested by cell lifters
(Sigma-Aldrich). The cell pellet was lysed using PhosphoSafe (EMD), sup-
plemented with protease inhibitor cocktail (Roche), and 0.5% wt/vol so-
dium azide. Equivalent protein loads were used for immunoprecipitation as
determined by Bichinchoninic Acid assay (Sigma-Aldrich). The antibody
used for immunoprecipitation was mouse anti-SU black 8–6 monoclonal
antibody (10). Immunoprecipitation and Western blotting were performed
as described previously (2). For detection, the antibodies used were either
goat anti-SU or rabbit anti-Syk N-19 (Santa Cruz Biotechnology, Inc.)
polyclonal antibodies. Donkey anti–goat IgG-alkaline phosphatase conju-
gated antibody or goat anti–rat IgG-alkaline phosphatase conjugated anti-
body was used as a secondary antibody (Jackson ImmunoResearch Labora-
tories). For development and quantification, an ECF substrate was used
followed by a scan using Storm 860 and analysis by ImageQuant 5.2 (all ob-
tained from Amersham Biosciences).
 
The in vitro human model of cell transformation.
 
The transform-
ing potential of MMTV envelope protein on human breast epithelial cells in 
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vitro was evaluated by using the spontaneously immortalized MCF-10F
cells. MCF-10F cells and the transfected stable pools derived from them
were maintained in DMEM:F-12 [1:1] medium with a 1.05 mM Ca
 
2
 
  con-
centration. Culture media were prepared by the Central Tissue Culture Fa-
cility at the Fox Chase Cancer Center. After transfection, the cells were as-
sayed for determination of survival efficiency, colony efficiency, colony
size, ductulogenic capacity, and invasiveness in Boyden chambers.
Colony formation in agar-methocel. This technique was used as an in
vitro assay for anchorage-independent growth, a parameter indicative of
transformation. All cell lines were suspended at a density of 2   104 cells/ml
in 2 ml of 0.8% methocel (Sigma-Aldrich) dissolved in DMEM:F-12 (1:1)
medium containing 20% horse serum. Cells from each transfection group
were plated in eight 24-well chambers precoated with 0.5 ml 5% agar base
in DMEM:F-12 medium. Cells were fed with fresh feeding medium con-
taining 0.8% methocel twice a week. The top four wells were stained with
neutral red 1:300 ratio at 24 h after plating, and the total number of viable
cells was counted at a magnification of 10. The bottom four wells were
maintained in culture for 21 d. After 21 d, these wells were stained with
neutral red and the number of colonies was counted. 10 colonies per well
were measured by using a graduated reticule under microscope at a magnifi-
cation of 10. Colony efficiency was determined by a count of the number
of colonies  63  m in diameter and expressed as a percentage of the origi-
nal number of viable cells after 24 h of plating.
Ductulogenesis in collagen matrix. This in vitro technique evaluates
the capacity of cells to differentiate by examining their ability to form three-
dimensional structures in a collagen matrix. Parental MCF-10F and trans-
fected cells were suspended at a final density of 2   103 cells/ml in 89.3%
Vitrogen100 collagen matrix (Collagen) and plated in four 24-well chambers
precoated with 89.3% collagen. The cells were fed with fresh feeding me-
dium containing 20% horse serum twice a week. The cells were examined
under an inverted microscope for a period of 21 d or longer to determine
whether they formed ductal structures or whether they grew as ball-like
spherical masses. The structures were photographed, fixed in 10% neutral
buffered formalin, embedded in paraffin, sectioned, and stained with hema-
toxylin-eosin for histological examination.
Invasion assay. BioCoat Matrigel Invasion Chambers (BD Biosciences)
provide cells with the conditions that allow assessment of their invasive
property in vitro. The invasion chambers were used according to the manu-
facturer’s instructions. In brief, trypsinized cells (2.5   104) were seeded in
the top chamber and incubated for 22 h at 37 C. High calcium medium
with 20% horse serum was used as a chemoattractant. The filters were fixed,
stained by Diff Quick (Sigma-Aldrich), cut out, and mounted onto glass
slides. The total number of cells that crossed the membrane was counted
under a light microscope.
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